Exome Asset Management LLC

SEC CIK: 0002011932
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Exome Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overview All 13F holders of DYN Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2025

Holdings of DYN by Exome Asset Management LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−195,933−100.0%	Sold out	Holders
Q2 2025	195,933	$1.87M	1.5%	−62,458−24.2%	Reduced	Holders
Q1 2025	258,391	$2.70M	2.4%	+258,391	New	Holders